ClearPoint Neuro (CLPT) EPS (Basic) Growth (3y) (2014 - 2026)
ClearPoint Neuro (CLPT) EPS (Basic) Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.59 Bn | 193.99 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 126.90 Bn | 123.42 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 118.28 Bn | 109.06 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 72.95 Bn | 72.41 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.59 Bn | 47.34 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.64 Bn | 31.53 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.08 Bn | 22.76 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 17.98% |
| 10 | ClearPoint Neuro | 459.29 Mn | 429.89 Mn | 6.71 Mn | -9.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.29% |
| Mar 31, 2026 | 10.40% |
| Dec 31, 2025 | -12.58% |
| Sep 30, 2025 | 22.83% |
| Jun 30, 2025 | 30.38% |
| Mar 31, 2025 | 23.19% |
| Dec 31, 2024 | 6.69% |
| Sep 30, 2024 | 40.35% |
| Jun 30, 2024 | 42.66% |
| Mar 31, 2024 | 49.39% |
| Dec 31, 2023 | -6.60% |
| Sep 30, 2023 | 7.04% |
| Jun 30, 2023 | -44.59% |
| Mar 31, 2023 | -40.91% |
| Dec 31, 2022 | -35.77% |
| Sep 30, 2022 | -77.99% |
| Jun 30, 2022 | -69.30% |
| Mar 31, 2022 | -61.27% |
| Dec 31, 2021 | -24.54% |
| Sep 30, 2021 | -86.00% |